Gallimune ND+IB+ART inj. emuls. i.m. vial

Land: Belgien

Sprache: Englisch

Quelle: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Wirkstoff:

Newcastle Disease Virus (inactivated) ; Avian Rhinotracheitis Virus (inactivated) ; Avian Coronavirus (inactivated)

Verfügbar ab:

Boehringer Ingelheim Animal Health Belgium SA-NV

ATC-Code:

QI01AA18

INN (Internationale Bezeichnung):

Paramyxovirus (Newcastle Disease Virus), Inactivated; Turkey Rhinotracheitis Virus (TRTV); Avian Infectious Bronchitis (IB) Virus

Darreichungsform:

Emulsion for injection

Zusammensetzung:

Paramyxovirus (Newcastle Disease Virus), Inactivated; Turkey Rhinotracheitis Virus (TRTV); Avian Infectious Bronchitis (IB) Virus

Verabreichungsweg:

Intramuscular use

Therapiegruppe:

poultry

Therapiebereich:

Avian Infectious Bronchitis Virus + Newcastle Disease Virus / Paramyxovirus + avian adenovirus + avian rhinotracheitis virus

Produktbesonderheiten:

CTI code: 353875-04 - Pack size: 10 x 1000 doses (300 (300) - Commercialisation status: NO - FMD code: 03661103055044 - CNK code: 3667151 - Delivery mode: Medical prescription; CTI code: 353875-01 - Pack size: 500 doses (150 (150) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 353875-03 - Pack size: 10 x 500 doses (150 (150) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 353875-02 - Pack size: 1000 doses (300 (300) - Commercialisation status: NO - Delivery mode: Medical prescription

Berechtigungsstatus:

Commercialised: No

Berechtigungsdatum:

2009-12-01